Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Neuropharmacology. 2018 Mar 28;135:412–423. doi: 10.1016/j.neuropharm.2018.03.036

Figure 6.

Figure 6

Grand-averaged AEPs from entorhinal cortex (ENT) and hippocampus (CA3) across the three drug conditions. Dashed red lines indicate peak-to-peak amplitudes of the P20-N40 components.